Page last updated: 2024-10-31

metyrapone and Amphetamine-Related Disorders

metyrapone has been researched along with Amphetamine-Related Disorders in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Amphetamine-Related Disorders: Disorders related or resulting from use of amphetamines.

Research Excerpts

ExcerptRelevanceReference
"Corticosterone levels were significantly different at the end of the 15-min session, but not following the 2-h session."1.39Combinations of oxazepam and metyrapone attenuate cocaine and methamphetamine cue reactivity. ( Cornett, EM; Goeders, NE; Guerin, GF; Keller, CM, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Keller, CM1
Cornett, EM1
Guerin, GF1
Goeders, NE1

Other Studies

1 other study available for metyrapone and Amphetamine-Related Disorders

ArticleYear
Combinations of oxazepam and metyrapone attenuate cocaine and methamphetamine cue reactivity.
    Drug and alcohol dependence, 2013, Dec-01, Volume: 133, Issue:2

    Topics: Amphetamine-Related Disorders; Analysis of Variance; Animals; Central Nervous System Stimulants; Coc

2013